Clinical on-site monitoring of ß-lactam antibiotics for a personalized antibiotherapy
Abstract An appropriate antibiotherapy is crucial for the safety and recovery of patients. Depending on the clinical conditions of patients, the required dose to effectively eradicate an infection may vary. An inadequate dosing not only reduces the efficacy of the antibiotic, but also promotes the e...
Enregistré dans:
Auteurs principaux: | R. Bruch, C. Chatelle, A. Kling, B. Rebmann, S. Wirth, S. Schumann, W. Weber, C. Dincer, G. Urban |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2017
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/bc35e50ee17a4018acd7b593716960cb |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Reversible inactivation of a peptidoglycan transpeptidase by a β-lactam antibiotic mediated by β-lactam-ring recyclization in the enzyme active site
par: Zainab Edoo, et autres
Publié: (2017) -
Antimicrobial Susceptibility to ß-lactams and Metronidazole of Microorganisms Isolated from Chronic and Aggressive Periodontitis
par: Gaetti-Jardim Júnior,Elerson, et autres
Publié: (2013) -
Heteroresistance to beta-lactam antibiotics may often be a stage in the progression to antibiotic resistance.
par: Victor I Band, et autres
Publié: (2021) -
A Natural Deep Eutectic Solvent Formulated to Stabilize β-Lactam Antibiotics
par: Belén Olivares, et autres
Publié: (2018) -
2-Day versus C-reactive protein guided antibiotherapy with levofloxacin in acute COPD exacerbation: A randomized controlled trial.
par: Msolli Mohamed Amine, et autres
Publié: (2021)